Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...
EMBARGOED UNTIL FRI, DEC. 15 – 5:00 A.M. Eastern Credit: Medical College of Wisconsin NEWS RELEASE EMBARGOED UNTIL FRI, DEC. 15 – 5:00 A.M. Eastern...
EMBARGOED UNTIL FRI, DEC. 15 – 5:00 A.M. Eastern Credit: Medical College of Wisconsin NEWS RELEASE EMBARGOED UNTIL FRI, DEC. 15 – 5:00 A.M. Eastern...
Before you start munching on magic mushrooms, it’s wise to learn about timelines. So, how long does a shroom trip last? Let’s find out.
MAPS Public Benefit Corporation (“MAPS PBC”), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
Historic filing marks first New Drug Application submission for any psychedelic-assisted therapy. The post Breaking News: MAPS Files New Drug Application...
Newly issued patent expected to provide protection until at least 2041 and includes composition of matter claims to pharmaceutical compositions within...
Potentially groundbreaking results as Cybin's Phase 2 Study of CYB003 in Major Depressive Disorder showed 79% of patients in remission after two 12mg doses. The...
New patent provides IP protection until at least 2041. Cybin’s patent portfolio now includes 39 granted patents and over 170 pending applications. The...